INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS

INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS

Indications for myocardial cytoprotector, trimetazidine, in patients with ischemic heart disease are analyzed and justified according to evidence based medicine. Results of a multicenter randomized comparative KARDIOKANON study are discussed in terms of efficacy and tolerability of two variants of t...

Full description

Saved in:

Bibliographic Details
Main Author:	Zh. M. Sizova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	ischemic heart disease chronic heart failure angina preconditioning cytoprotection trimetazidine original drug generic pharmacotherapy
Online Access:	https://www.rpcardio.online/jour/article/view/285
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE
by: N. Yu. Karpova, et al.
Published: (2015-09-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

PREINFARCTION ANGINA AS A CLINICAL FORM OF THE ISCHEMIC PRECONDITIONING PHENOMENON
by: E. A. Lykasova, et al.
Published: (2014-06-01)

ENDOTHELIAL DYSFUNCTION AND ITS CORRECTION WIT CYTOPROTECTORS IN PATIENTS WITH STABLE EFFORT ANGINA AND ARTERIAL HYPERTENSION
by: F. E. Khlebodarov, et al.
Published: (2009-12-01)

Pre-infarction angina and ischemic pre-conditioning role in coronary reserve protection during early post-infarction period
by: A. P. Ivanov, et al.
Published: (2006-02-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE
by: A. N. Zakirova, et al.
Published: (2016-01-01)

New potential of Trimetazidine MB for coronary heart disease treatment in the real-world clinical practice: results of the Russian multi-centre randomised study PERSPECTIVE (Part II)
by: M. G. Bubnova, et al.
Published: (2011-12-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

EFFECT OF CYTOPROTECTION ON THE OXIDATIVE PROCESSES AND ENDOTHELIAL FUNCTION IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE
by: A. V. Shabalin, et al.
Published: (2016-01-01)

THE PROBLEM OF MEDICINES INTERCHANGEABILITY. FOCUS ON PERINDOPRIL
by: A. I. Malyhina, et al.
Published: (2015-09-01)

THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY)
by: S. V. Povetkin, et al.
Published: (2018-03-01)

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease
by: E. I. Tarlovskaya, et al.
Published: (2016-03-01)

Myocardial cytoprotectors demonstrate anti-apoptotic effect on vascular endotheliocytes
by: A. I. Inzhutova
Published: (1970-01-01)

RANOLAZINE IN ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2015-12-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

EFFECT OF FERROTHERAPY ON COURSE OF ISCHEMIC HEART DISEASE ASSOCIATED WITH MILD IRON DEFICIENCY IN MEN
by: N. S. Belousova, et al.
Published: (2016-01-01)

INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS)
by: A. V. Kontsevaja, et al.
Published: (2016-01-01)

EFFICACY OF PHYSICAL TRAININGS AS CARDIOPROTECTION METHOD FOR CORONARY BYPASS SURGERY
by: Yu. A. Argunova, et al.
Published: (2018-07-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

Bisoprolol in cardiovascular disease treatment
by: S. N. Tolpygina, et al.
Published: (2008-12-01)

Protective ischemia in cardiology. Myocardial conditioning forms
by: V. P. Lupanov, et al.
Published: (2011-02-01)

TREATMENT ADHERENCE AND QUALITY OF LIFE OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE IN TREATMENT WITH NICORANDIL: INTERRELATION AND INTERACTION (ACCORDING TO THE RESULTS OF THE OBSERVATIONAL STUDY NIKEA)
by: S. Yu. Martsevich, et al.
Published: (2018-07-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2016-01-01)

Myocardial cytoprotectors and lipid peroxidation in stable angina patients before and after myocardial revascularization
by: I. G. Gordeev, et al.
Published: (2005-06-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

New perspectives in optimizing treatment of coronary heart disease and arterial hypertension patients
by: N. A. Nikolaev
Published: (2008-02-01)

ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2016-01-01)